Xenon Pharmaceuticals Inc (XENE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for XENE. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 7,522,482 | $454M | INCREASED |
| State Street | 1,969,629 | $119M | INCREASED |
| Pictet Asset Management Holding | 1,187,723 | $72M | INCREASED |
| Panagora Asset Management | 664,031 | $40M | NEW |
| Timessquare Capital Management | 451,593 | $27M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Gillian Cannon (Director) | SELL | 1,190 | $63K | 2026-06-05 |
| Gary Patou (Director) | SELL | 1,322 | $70K | 2026-06-05 |
| Dawn Svoronos (Director) | AWARD | 1,593 | 2026-06-01 | |
| Dawn Svoronos (Director) | AWARD | 10,507 | $562K | 2026-06-01 |
| Dawn Svoronos (Director) | SELL | 1,416 | $76K | 2026-06-01 |
Full institutional holdings, insider history, and congressional trades for Xenon Pharmaceuticals Inc on SentiSense.